Depo-subq Provera 104

   
Google
 
Web NewDrugInformation.com

Depo-subq Provera 104


Drug - Depo-subq Provera 104
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; SUBCUTANEOUS
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Medroxyprogesterone Acetate
Multiple ingredients are in alphabetical order.

Strength - 104MG/0.65ML
The potency of the active ingredient(s), Medroxyprogesterone Acetate. May repeat for multiple part products.

Applicant - PFIZER
The firm name holding legal responsibility for Depo-subq Provera 104. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021583
The FDA assigned number to Depo-subq Provera 104. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Depo-subq Provera 104. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 17, 2004
The date Depo-subq Provera 104 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Depo-subq Provera 104. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Depo-subq Provera 104 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Agricultural Div
The full name of the firm holding legal responsibility for the new application of Depo-subq Provera 104.

Depo-subq Provera 104